Dupixent

Dupixent (Dupilumab) is a biologic medication used for treating moderate-to-severe eczema and other inflammatory conditions. This subcutaneous injection helps manage symptoms and improve quality of life for eligible patients.

Dupixent is primarily used for the treatment of moderate-to-severe atopic dermatitis (eczema) in adults and children. It may also be prescribed for other inflammatory conditions such as asthma or chronic rhinosinusitis with nasal polyposis. Dupilumab works by targeting specific pathways involved in inflammation, helping to reduce symptoms and improve overall skin condition.

Common effects of Dupixent may include injection site reactions, eye and eyelid inflammation, and cold symptoms. Some users may experience joint pain or changes in blood tests. These effects vary among individuals and are not experienced by everyone.

Dupixent should be used under medical supervision. It is important to inform your healthcare provider about any allergies or existing medical conditions before starting treatment. Regular monitoring may be required to assess the effectiveness and safety of the medication.

Dupixent may interact with other medications, including those that affect the immune system. It is advisable to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness of Dupilumab.